Shionogi & Co., Ltd. (ADR)
General ticker "SGIOY" information:
- Sector: Health Care
- Industry: Drug Manufacturers - Specialty & Generic
- Capitalization: $12.0B (TTM average)
Shionogi & Co., Ltd. (ADR) follows the US Stock Market performance with the rate: 30.5%.
Estimated limits based on current volatility of 1.3%: low 10.04$, high 10.31$
Factors to consider:
- Company pays dividends (semi-annually): last record date 2025-09-30, amount 0.09$ (Y1.77%)
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-03-31 to 2027-03-31
- 2025-03-31 to 2026-03-31 estimated range: [6.72$, 9.90$]
- 2026-03-31 to 2027-03-31 estimated range: [7.11$, 10.45$]
Financial Metrics affecting the SGIOY estimates:
- Positive: with PPE of 14.7 at the end of fiscal year the price was low
- Positive: Operating profit margin, % of 36.46 > 18.52
- Positive: 6.68 < Operating cash flow per share per price, % of 10.03
- Negative: negative Industry operating cash flow (median)
- Negative: 0 < Inventory ratio change, % of 0.01
- Positive: Interest expense per share per price, % of 0.46 <= 0.73
- Negative: Industry earnings per price (median), % of 0 <= 0
- Negative: negative Industry operating income (median)
- Positive: Return on assets ratio (scaled to [-100,100]) of 9.94 > 6.12
Short-term SGIOY quotes
Long-term SGIOY plot with estimates
Financial data
| YTD | 2024-03-31 | 2025-03-31 |
|---|---|---|
| Operating Revenue | ¥435,081.00MM | ¥438,268.00MM |
| Operating Expenses | ¥263,621.00MM | ¥278,489.00MM |
| Operating Income | ¥171,460.00MM | ¥159,779.00MM |
| Non-Operating Income | ¥26,823.00MM | ¥40,971.00MM |
| Interest Expense | ¥6,701.00MM | ¥9,027.00MM |
| R&D Expense | ¥102,640.00MM | ¥108,612.00MM |
| Income(Loss) | ¥198,283.00MM | ¥200,750.00MM |
| Taxes | ¥37,708.00MM | ¥31,215.00MM |
| Profit(Loss)* | ¥162,030.00MM | ¥170,434.00MM |
| Stockholders Equity | ¥1,235,326.00MM | ¥1,361,924.00MM |
| Inventory | ¥64,916.00MM | ¥65,477.00MM |
| Assets | ¥1,416,918.00MM | ¥1,535,349.00MM |
| Operating Cash Flow | ¥154,284.00MM | ¥195,460.00MM |
| Capital expenditure | ¥28,267.00MM | ¥17,126.00MM |
| Investing Cash Flow | ¥5,922.00MM | ¥-129,069.00MM |
| Financing Cash Flow | ¥-126,853.00MM | ¥-51,919.00MM |
| Earnings Per Share** | ¥93.08 | ¥100.18 |
| Ordinary share to ADR | 1.00x | 1.00x |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.